Correlation Between Enanta Pharmaceuticals and Eyenovia
Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Eyenovia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Eyenovia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enanta Pharmaceuticals and Eyenovia, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Eyenovia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Eyenovia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Eyenovia.
Diversification Opportunities for Enanta Pharmaceuticals and Eyenovia
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Enanta and Eyenovia is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Eyenovia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyenovia and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Eyenovia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyenovia has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Eyenovia go up and down completely randomly.
Pair Corralation between Enanta Pharmaceuticals and Eyenovia
Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to generate 0.12 times more return on investment than Eyenovia. However, Enanta Pharmaceuticals is 8.12 times less risky than Eyenovia. It trades about -0.5 of its potential returns per unit of risk. Eyenovia is currently generating about -0.24 per unit of risk. If you would invest 1,111 in Enanta Pharmaceuticals on September 3, 2024 and sell it today you would lose (251.00) from holding Enanta Pharmaceuticals or give up 22.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enanta Pharmaceuticals vs. Eyenovia
Performance |
| Timeline |
| Enanta Pharmaceuticals |
| Eyenovia |
Enanta Pharmaceuticals and Eyenovia Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enanta Pharmaceuticals and Eyenovia
The main advantage of trading using opposite Enanta Pharmaceuticals and Eyenovia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Eyenovia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will offset losses from the drop in Eyenovia's long position.| Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
| Eyenovia vs. DiaMedica Therapeutics | Eyenovia vs. Lyra Therapeutics | Eyenovia vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |